BlackRock Japan’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$9.59M Sell
66,851
-10,689
-14% -$1.36M 0.03% 547
2016
Q3
$9.16M Sell
77,540
-1,934
-2% -$232K 0.03% 549
2016
Q2
$8.42M Sell
79,474
-5,647
-7% -$630K 0.03% 555
2016
Q1
$9.48M Buy
85,121
+2,776
+3% +$351K 0.04% 518
2015
Q4
$12.9M Buy
82,345
+19,564
+31% +$2.85M 0.05% 417
2015
Q3
$8.24M Buy
62,781
+4,810
+8% +$771K 0.03% 541
2015
Q2
$10.1M Buy
57,971
+57,840
+44,153% +$10.4M 0.04% 513
2015
Q1
$23K Sell
131
-14
-10% -$2.13K ﹤0.01% 1172
2014
Q4
$19K Sell
145
-30
-17% -$3.87K ﹤0.01% 1217
2014
Q3
$23K Sell
175
-17,487
-99% -$1.8M ﹤0.01% 1145
2014
Q2
$1.56M Sell
17,662
-16,992
-49% -$1.63M 0.01% 676
2014
Q1
$3.26M Buy
34,654
+10,344
+43% +$1.06M 0.01% 658
2013
Q4
$2.75M Buy
24,310
+15,848
+187% +$1.43M 0.01% 657
2013
Q3
$667K Buy
8,462
+2,728
+48% +$199K ﹤0.01% 725
2013
Q2
$377K Buy
+5,734
New +$369K ﹤0.01% 767

Other funds holding UTHR

BlackRock Japan's UTHR Position: Q4 2016 in Review

BlackRock Japan reduced its United Therapeutics (UTHR) stake by 14% in Q4 2016, selling an estimated $1.36M and leaving 66,851 shares worth $9.59M. The position accounts for 0.03% of the portfolio, ranked #547.

BlackRock Japan first reported a position in UTHR in Q2 2013 and has held it in 15 quarters since. The position peaked at $12.9M in Q4 2015. 406 funds tracked by Wall St. Rank hold UTHR as of Q4 2016.

  • BlackRock Japan held 66,851 shares of United Therapeutics worth $9.59M as of Q4 2016.
  • BlackRock Japan sold 10,689 United Therapeutics shares in Q4 2016, an estimated $1.36M.
  • United Therapeutics made up 0.03% of BlackRock Japan's portfolio in Q4 2016, its #547 holding.
  • BlackRock Japan first reported a position in United Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Japan's United Therapeutics position peaked at $12.9M in Q4 2015.
  • 406 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.